Evaluation of efficacy and safety of Polyherbal Unani formulations, Itrifal Shahtara orally and Marham Kharish Jadeed topically in the management of N ?r F ?rsi (Eczema) - NI

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients who are willing and able to comply with the scheduled visits and treatment plan, laboratory testing and other study procedure and capable of providing a signed informed consent form indicating the subject has been informed of all pertinent aspects of the study.

•1.Patients with an evidence of clinically significant and uncontrolled systemic illness.
•2.Patients with a current diagnosis of active skin disease (e.g., psoriasis, lupus erythematosus) or skin infection (bacterial, fungal or viral) especially in place of eczema at the same time.
•3. Patients who had been using topical steroids within past 14 days.
•4. Pregnant and lactating women.
•5. Patients who have a known history or clinically relevant allergy, in particular to any component of the study treatment.
•6. Patients unlikely to cooperate with the study protocol.

发起方

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush